The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
Retatrutide and Tirzepatide combination formulations are studied in laboratory research examining multi-receptor incretin signaling pathways and metabolic regulatory mechanisms.